Biotech Breakthroughs
Invest in

Biotech Breakthroughs

15.5%
16.2%
3.1%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
15.5%
16.2%
3.1%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
33.0% Cancer 6.7%
17.9% Amgen Inc AMGN 0.3%
12.3% Celgene Corp. CELG 15.1%
1.8% Seattle Genetics Inc. SGEN 1.0%
1.0% Spectrum Pharmaceuticals Inc. SPPI 32.2%
19.4% Infectious Diseases 9.4%
16.7% Gilead Sciences Inc. GILD 12.2%
1.9% Emergent Biosolutions Inc. EBS 29.5%
0.9% Opko Health Inc. OPK 37.3%
18.4% Other Diseases 4.1%
5.7% Alexion Pharmaceuticals Inc. ALXN 18.0%
5.6% Regeneron Pharmaceuticals Inc. REGN 0.3%
3.3% Vertex Pharmaceuticals Incorporated VRTX 17.8%
2.2% United Therapeutics Corporation UTHR 13.5%
1.6% Ligand Pharmaceuticals Incorporated LGND 76.6%
15.6% Autoimmune Disorders 27.2%
9.6% Biogen Inc BIIB 32.0%
2.3% BioMarin Pharmaceutical Inc. BMRN 25.6%
2.1% Incyte Corp. INCY 4.3%
1.5% Xencor Inc XNCR 30.4%
13.6% Research & Diagnostics 7.5%
5.6% Quintiles Transnational Holdings Q 2.7%
3.2% Illumina Inc. ILMN 26.3%
2.9% Qiagen N.V. QGEN 7.1%
1.9% Meridian Bioscience Inc. VIVO 9.9%

Quotes delayed 15 mins. Currently Feb 7, 2016 3:19:45 AM. Fields are marked with -- when data is unavailable.